PCN136 - A COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN CANADA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.219
https://www.valueinhealthjournal.com/article/S1098-3015(18)33519-8/fulltext
Title :
PCN136 - A COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN CANADA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33519-8&doi=10.1016/j.jval.2018.09.219
First page :
Section Title :
Open access? :
No
Section Order :
1556